<DOC>
	<DOCNO>NCT00909129</DOCNO>
	<brief_summary>The purpose study investigate T-cell mediate immune response HIV-1 HCV determine response affect HCV treatment correlate response . Furthermore , study Interferon-inducible protein-10 ( IP-10 ) dynamic HCV treatment , correlate treatment outcome .</brief_summary>
	<brief_title>Interactions Hepatitis C Viral ( HCV ) Dynamics Immune Activation HIV Coinfected Patients During HCV Treatment</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>HIV1 Hepatitis C coinfected adult patient Hepatitis C treatment naive Stable HIV1 infection without cART &gt; 300 CD4+ cell count Decompensated liver disease Ongoing depression Ongoing drug abuse Other contraindication interferon ribavirin treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>Immune activation</keyword>
	<keyword>HCV kinetics</keyword>
	<keyword>IP-10</keyword>
</DOC>